Long acting pharmaceutical compositions
AssigneeGlaxo Smith Kline Intellectual Property (No.) Limited
InventorBrian Alvin JOHNS
Life of this patent
Estimating the term…
Abstract
The present invention relates to long acting pharmaceutical compositions or pharmaceutically acceptable salts thereof, useful in the treatment or prevention of Human Immunodeficiency Virus (HIV) infections.
Claims57
A long acting parenteral (LAP) pharmaceutical composition comprising a pharmaceutically acceptable excipient and a first compound of the structure:
- or a pharmaceutically acceptable salt thereof,
- in combination with a second compound of the structure:
- or a pharmaceutically acceptable salt thereof.
A long acting parenteral (LAP) pharmaceutical composition comprising a pharmaceutically acceptable excipient and a first compound of the structure:
- or a pharmaceutically acceptable salt thereof,
- in combination with a second compound of the structure:
- or a pharmaceutically acceptable salt thereof.
A long acting parenteral (LAP) pharmaceutical composition comprising a pharmaceutically acceptable excipient and a first compound of the structure:
- or a pharmaceutically acceptable salt thereof,
- in combination with:
- a) a second compound of the structure:
- or a pharmaceutically acceptable salt thereof, and
- b) a third compound, TMC-278 of the structure:
A long acting parenteral (LAP) pharmaceutical composition comprising a pharmaceutically acceptable excipient and a first compound of the structure:
- or a pharmaceutically acceptable salt thereof,
- in combination with:
- a) a second compound of the structure:
- or a pharmaceutically acceptable salt thereof, and
- b) a third compound of the structure:
A method of preventing or treating an HIV infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a long acting parenteral (LAP) pharmaceutical composition comprising a pharmaceutically acceptable excipient and a first compound of the structure:
- or a pharmaceutically acceptable salt thereof,
- in combination with a second compound of the structure:
- or a pharmaceutically acceptable salt thereof.
A method of preventing or treating an HIV infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a long acting parenteral (LAP) pharmaceutical composition comprising a pharmaceutically acceptable excipient and a first compound of the structure:
- or a pharmaceutically acceptable salt thereof,
- in combination with a second compound of the structure:
- or a pharmaceutically acceptable salt thereof.
A method of preventing or treating an HIV infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a long acting parenteral (LAP) pharmaceutical composition comprising a pharmaceutically acceptable excipient and a first compound of the structure:
- or a pharmaceutically acceptable salt thereof,
- in combination with:
- a) a second compound of the structure:
- or a pharmaceutically acceptable salt thereof, and
- b) a third compound of the structure:
A method of preventing or treating an HIV infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a long acting parenteral (LAP) pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the structure:
- or a pharmaceutically acceptable salt thereof,
- in combination with:
- a) a second compound of the structure:
- or a pharmaceutically acceptable salt thereof, and
- b) a third compound of the structure:
Dependencies are inferred from the claim text.